Cargando…
Serum neuron-specific enolase (S-NSE) and the prognosis in small-cell lung cancer (SCLC): a combined multivariable analysis on data from nine centres.
The influence of pretreatment serum neuron-specific enolase (S-NSE) in addition to more conventional prognostic factors on survival duration in small-cell lung cancer (SCLC) was investigated in 770 patients from nine centres in six countries. The other variables included stage of disease, performanc...
Autores principales: | Jørgensen, L. G., Osterlind, K., Genollá, J., Gomm, S. A., Hernández, J. R., Johnson, P. W., Løber, J., Splinter, T. A., Szturmowicz, M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074633/ https://www.ncbi.nlm.nih.gov/pubmed/8695366 |
Ejemplares similares
-
Serum neuron-specific enolase (S-NSE) in progressive small-cell lung cancer (SCLC).
por: Jørgensen, L. G., et al.
Publicado: (1994) -
Serum neuron-specific enolase (S-NSE) and the prognosis in small-cell lung cancer (SCLC): a combined multivariable analysis on data from nine centres
Publicado: (1996) -
Serum neuron specific enolase (NSE) is a determinant of response duration in small cell lung cancer (SCLC).
por: Jørgensen, L. G., et al.
Publicado: (1992) -
GFAP and Neuron Specific Enolase (NSE) in the Serum of Suicide Attempters
por: Bagheri, Maryam, et al.
Publicado: (2022) -
Enhanced Expression of Neuron‐specific Enolase (NSE) in Pyothorax‐associated Lymphoma (PAL)
por: Nakatsuka, Shin‐ichi, et al.
Publicado: (2002)